by April Breyer Menon | Jun 28, 2021
Venable Fizpatrick partner Ha Kung Wong spoke with Part B News about the Supreme Court’s opinion in California v. Texas, upholding the Affordable Care Act (ACA) for the third time, as well as another upcoming case regarding the ACA, Kelley v. Becerra. The...
by April Breyer Menon | Jun 22, 2021
On June 21, 2021, the Supreme Court in United States v. Arthrex Inc., No. 19-1434, held that the authority wielded by administrative patent judges (APJs) in inter partes review proceedings (IPRs) violates the Appointments Clause of the Constitution. The Supreme Court...
by April Breyer Menon | Jun 17, 2021
Download PDF Download...
by April Breyer Menon | Jun 15, 2021
On June 25, 2021, the Biological Product Patent Transparency (BPPT) amendments to 42 U.S.C. 262(k) of the Biologics Price Competition and Innovation Act (BPCIA) will take effect. Those amendments make publication of the FDA “Purple Book” mandatory; require...
by April Breyer Menon | May 20, 2021
Venable’s Ha Kung Wong participated in a panel discussion of antitrust issues relating to IP litigations in the pharmaceutical industry. This is the second webinar in a three-part series, discussing patent infringement lawsuits from the perspectives of...